Skip to main content
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1966;59(Suppl 1):64–68.

Errors in Providing Data for Statistical Analysis

B W Cromie
PMCID: PMC1900644  PMID: 5332060

Full text

PDF
64

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECKETT A. H., ROWLAND M., TURNER P. INFLUENCE OF URINARY PH ON EXCRETION OF AMPHETAMINE. Lancet. 1965 Feb 6;1(7380):303–303. doi: 10.1016/s0140-6736(65)91033-0. [DOI] [PubMed] [Google Scholar]
  2. Burns J. J., Conney A. H. Enzyme stimulation and inhibition in the metabolism of drugs. Proc R Soc Med. 1965 Nov;58(11 Pt 2):955–960. doi: 10.1177/003591576505811P203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CLARK M. L., RAY T. S., PAREDES A., COSTILOE J. P., CHAPPELL J. S., HAGANS J. A., WOLF S. Chlorpromazine in chronic schizophrenic women: I. Experimental design and effects at maximum point of treatment. Psychopharmacologia. 1961;2:107–136. doi: 10.1007/BF00592679. [DOI] [PubMed] [Google Scholar]
  4. GROSSER H. H., RYAN E. DRUG TREATMENT OF ANXIETY: A CONTROLLED STUDY OF OPIPRAMOL AND CHLORDIAZEPOXIDE. Br J Psychiatry. 1965 Feb;111:134–141. doi: 10.1192/bjp.111.471.134. [DOI] [PubMed] [Google Scholar]
  5. HOFFER A., OSMOND H. Double blind clinical trials. J Neuropsychiatr. 1961 Jun;2:221–227. [PubMed] [Google Scholar]
  6. KERR D. N., DAVIDSON S. Gastrointestinal intolerance to oral iron preparations. Lancet. 1958 Sep 6;2(7045):489–492. doi: 10.1016/s0140-6736(58)91282-0. [DOI] [PubMed] [Google Scholar]
  7. MAINLAND D. The clinical trial--some difficulties and suggestions. J Chronic Dis. 1960 May;11:484–496. doi: 10.1016/0021-9681(60)90013-8. [DOI] [PubMed] [Google Scholar]
  8. MATTHEWS A. E. Double-blind trials of promazine in labour. Br Med J. 1963 Aug 17;2(5354):423–427. doi: 10.1136/bmj.2.5354.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MODELL W., HOUDE R. W. Factors influencing clinical evaluation of drugs; with special reference to the double-blind technique. J Am Med Assoc. 1958 Aug 30;167(18):2190–2199. doi: 10.1001/jama.1958.72990350005006. [DOI] [PubMed] [Google Scholar]
  10. Milne M. D. Influence of acid-base balance on efficacy and toxicity of drugs. Proc R Soc Med. 1965 Nov;58(11 Pt 2):961–963. doi: 10.1177/003591576505811P204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. UHLENHUTH E. H., CANTER A., NEUSTADT J. O., PAYSON H. E. The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo. Am J Psychiatry. 1959 Apr;115(10):905–910. doi: 10.1176/ajp.115.10.905. [DOI] [PubMed] [Google Scholar]
  12. WOLF S., PINSKY R. H. Effects of placebo administration and occurrence of toxic reactions. J Am Med Assoc. 1954 May 22;155(4):339–341. doi: 10.1001/jama.1954.03690220013004. [DOI] [PubMed] [Google Scholar]
  13. WOLF S. Symposium on clinical drug evaluation and human pharmacology. IV. Placebos: problems and pitfalls. Clin Pharmacol Ther. 1962 Mar-Apr;3:254–257. doi: 10.1002/cpt196232254. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES